NEWM&A

Capricor Therapeutics (CAPR) Files Form 144 on May 19

Published on 5/19/2026

#CAPR#Form144#securities
Capricor Therapeutics (CAPR) Files Form 144 on May 19

AI Summary

Capricor Therapeutics (CAPR) submitted Form 144 on May 19, indicating the intention to sell shares for a specified amount. This filing is a regulatory requirement for sellers of restricted securities. The document helps investors understand potential selling pressure on the stock. Such transactions may impact trading volumes and share price.

Source: Read original article (opens in new tab)

Related News

Insurers Raise Premiums Amid Middle East Conflict in 2026
M&A

Insurers Raise Premiums Amid Middle East Conflict in 2026

May 19

Genuine Parts Company (GPC) Form 144 Filing on May 19
M&A

Genuine Parts Company (GPC) Form 144 Filing on May 19

May 19

Standard Chartered (STAN) to Acquire Zodia Custody Pending Regulatory Approval
M&A

Standard Chartered (STAN) to Acquire Zodia Custody Pending Regulatory Approval

May 19

Onto Innovation (ONTO) Prices $1.3 Billion Convertible Notes Offering
M&A

Onto Innovation (ONTO) Prices $1.3 Billion Convertible Notes Offering

May 19